Eastwood Bio-Medical Canada Inc. markets and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. The company distributes Eleotin, which provides natural remedies for metabolic disorders, such as blood glucose disorders, hypertension, and obesity. Its licensed products include Eleotin A 700 for the treatment for spleen deficiency, lack of appetite, and fatigue; Eleotin AL88 for laxative; Eleotin Cal20 for bone and teeth maintenance; Eleotin V3D for development and maintenance of bones, teeth, and good health; Eleotin G2000 for cardiovascular health; Eleotin H55 for sedative and tension relief; and Eleotin Zn330 for tissue formation and metabolism. The company’s products also include Eleotin Bentley to promote healthy glucose levels; and Eleotin LBM for hypertension relief. The company was incorporated in 2010 and is based in Richmond, Canada. Eastwood Bio-Medical Canada Inc. is a subsidiary of Eastwood Bio-Medical Research Inc.
Metrics to compare | EBM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipEBMPeersSector | |
---|---|---|---|---|
P/E Ratio | −58.3x | −0.1x | −0.5x | |
PEG Ratio | −3.49 | 0.02 | 0.00 | |
Price/Book | −19.3x | 0.9x | 2.6x | |
Price / LTM Sales | 36.1x | 0.8x | 3.0x | |
Upside (Analyst Target) | - | 8.2% | 52.6% | |
Fair Value Upside | Unlock | 5.7% | 8.7% | Unlock |